Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Age >65, male gender, diagnosis of symptomatic Waldenström macroglobulinemia and b2m >3 are significant predictors for shorter OS in IgM gammopathy; BM bx infiltration, Hgb <11.5, plts <100k assoc w/ shorter time to 1st tx.”
Title: Quantitative MYD88 L265P and flow cytometry levels for outcome determination in IgM gammopathies: the SAL-TO study
Authors: Irene Dogliotti, Cristina Jiménez, Veronica Peri, Martina Ferrante, Davide Musto, Silvio Mercadante, Gian Maria Zaccaria, Marco Ghislieri, Giulia Benevolo, Enrique M. Ocio, Araceli Rubio-Martínez, Ilda Murillo, Fernando Escalante, Carmen Aguilera, Aránzazu García-Mateo, Alfonso García de Coca, Roberto Hernández-Martin, Julio Davila-Valls, Federica Cavallo, Noemi Puig, Veronica Gonzalez-Calle, Maria Eugenia Sarasquete, Miguel Alcoceba, Simone Ragaini, Michele Clerico, Chiara Consoli, Enrico Amaducci, María García-Álvarez, María del Carmen Carmen Chillón, Alejandro Medina-Herrera, Marcos González, Norma C. Gutierrez, Benedetto Bruno, Daniela Drandi, Simone Ferrero, Ramón García-Sanz
You can read the Full Article in Blood Advances.
You can find other articles featuring Robert Orlowski on OncoDaily.
